Ting Therapeutics Advances TT004 into Phase Ib Clinical Trials as a Potential Cisplatin Chemoprotective Therapy
San Diego, California Oct 22, 2026 (Issuewire.com) - Ting Therapeutics Advances TT004 into Phase Ib Clinical Trial as a Potential Chemoprotective Therapy for Cisplatin-Treated Patients
- China IND Approved;
- Phase Ib Trial Set to Begin Recruiting Patients at Eye and ENT Hospital of Fudan University in Shanghai
Ting Therapeutics, Inc., a biotechnology company developing therapies for treatment-related tissue injury, today announced that its lead candidate, TT004, has received IND approval in China and is advancing into Phase Ib clinical development as a potential chemoprotective therapy for patients receiving cisplatin chemotherapy.
Cisplatin is a highly effective cancer treatment, but its toxicities can substantially limit therapy. Approximately 40% of patients discontinue or modify chemotherapy because of treatment-related toxicities. Cisplatin can also cause permanent hearing loss in up to 80% of patients and acute kidney injury in approximately 30% of patients.
TT004 is designed to protect normal tissues from cisplatin toxicity while preserving its anticancer activity. In preclinical studies, TT004 increased survival following cisplatin exposure three-fold and reduced cisplatin-induced hearing loss and kidney injury by approximately 70%, without compromising cisplatin's anticancer effects.
"These findings support our vision of TT004 as a chemoprotective therapy that could improve the tolerability of cisplatin while maintaining its anticancer efficacy," said Jian Zuo, PhD, Co-Founder and CEO of Ting Therapeutics. "Our goal is to reduce the suffering caused by cisplatin treatment-related toxicities, help more patients receive and complete effective chemotherapy, and improve their long-term quality of life."
Ting Therapeutics recently licensed its China rights for TT004 to Rising Dragon, a Chinese biotechnology company, for development in China. The companies jointly developed TT004 as an oral tablet and obtained IND approval from China's Center for Drug Evaluation (CDE) for first-in-human clinical evaluation.
The Phase Ib trial, conducted in collaboration with oncologists and otolaryngologists at Eye and ENT Hospital of Fudan University in Shanghai, will evaluate the safety and tolerability of oral TT004 administered with standard-of-care cisplatin chemotherapy in patients with head and neck cancer. The study has received institutional ethics approval and is preparing to initiate patient recruitment.
TT004's protective effects have been demonstrated only in preclinical models and have not yet been shown in humans. This trial is the first clinical evaluation of TT004 and an important step toward determining whether these effects can be translated to cancer patients.
About Ting Therapeutics
Founded in 2018, Ting Therapeutics, Inc. develops novel and repurposed therapeutics to prevent and treat hearing loss and other treatment-related tissue injuries. The Company's pipeline targets hearing loss associated with chemotherapy, noise exposure, antibiotics, aging, and other causes.
Contact:
Jian Zuo, PhD, Co-Founder & CEO
Ting Therapeutics, Inc.
6868 Nancy Ridge Dr., San Diego, CA 92121
[email protected]
Source :Ting Therapeutics, Inc.
This article was originally published by IssueWire. Read the original article here.
More News
Rare Suu Kyi phone call to son signals shift in Myanmar junta strategy
The son of Myanmar’s Aung San Suu Kyi said she sounded “fairly healthy” after speaking to the detained ex-democratic leader on Thursday for the first time in more than five years. Suu Kyi, 81, is under house arrest in the capital, Naypyidaw, according to Myanmar authorities, where she has been sequestered since being unseated in a 2021 military coup. “She was sounding fairly healthy,” Kim Aris, who lives in the UK, said after the telephone conversation. It was the first time he had spoken to his...
/file/attachments/orphans/najib23121_480507.png)
Najib's 'jasa' does not excuse corruption, student activist tells ex-PM's supporters
Law undergraduate says the same principle must also apply to the current government.
Indonesia unleashes 3.2 tons of dry ice from above as wildfire smoke engulfs Southeast Asia
Indonesia has taken to the skies to tackle persistent wildfire haze, dropping more than 3.2 tons of dry ice over Palembang to clear smoke choking parts of the country and its neighbors.
Four Hope Bridges worth over $89,000 open in Mekong Delta
Four concrete bridges costing more than VND2.3 billion (US$89,000) have opened in Dong Thap Province and Can Tho City, improving rural transport and helping residents move agricultural produce more easily.
Vietnam partners with Denmark to propel its wind energy ambition
A wind energy partnership between Vietnam and Denmark has fuelled expectations of the Southeast Asian country boosting its competitiveness in renewable electricity to serve overseas and domestic markets. Vietnam is well placed to grow its renewable electricity sector by tapping its large pool of engineering talent and abundant wind resources with help from Denmark, a global leader in wind energy, according to analysts. On Tuesday, the two countries signed a comprehensive strategic partnership...
At least 16 dead in Tibet quake: China state media
At least 16 people were killed and 32 more injured when a strong 7.0-magnitude earthquake struck China's remote Tibet region, state news agency Xinhua said, citing local authorities.
/file/attachments/orphans/SR_MP_138375.png)
Teacher charged with sexually abusing pupils, but were warning signs missed for years?
Mkini's probe finds alleged disturbing lack of action over the years.
Sengkang Town Council bans pickleball on certain courts too close to residential units
Other town councils had previously taken similar measures.
NUS student, 23, sticks phone though bathroom window to film female housemate, says it gives him a thrill
Police investigations revealed that he had filmed the woman 10 times within two months.
Toa Payoh wanton mee stall closes temporarily after owner, 57, gets diagnosed with Stage 4 cancer
He received his diagnosis on his birthday.
Syed Saddiq hits back at Indonesian ex-minister's haze accusations, says he'll not shield polluters in M'sia
The Indonesian ex-trade minister accused Syed of using the haze to score political points and argued that Malaysian plantation companies should also be held accountable.
Lao Ban Soya Beancurd draws flak over 10¢ BCRS deposit, clarifies its drinks fall under return scheme
Their soya milk products fall under the pre-packaged drinks category.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.